4//SEC Filing
CARLO DENNIS J PHD 4
Accession 0001593968-19-001172
CIK 0000887247other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:20 PM ET
Size
7.0 KB
Accession
0001593968-19-001172
Insider Transaction Report
Form 4
CARLO DENNIS J PHD
DirectorPresident/CEO10% Owner
Transactions
- Sale
Common Stock
2019-05-20$1.73/sh−11,184$19,339→ 364,407 total
Holdings
- 250,709(indirect: By Trust)
Common Stock
- 5,883(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in March 2019.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.81, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001038322
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:20 PM ET
- Size
- 7.0 KB